Bayer Zydus Pharma

General Medicine

The General Medicine Unit provides an extensive range of products that offer both doctors and patients options for the treatment and prevention of acute diseases across a broad range of illnesses. These products, prescribed by general practitioners as well as medical specialists, help patients to control high blood pressure, prevent myocardial infarction and stroke, manage diabetes and treat bacterial infections such as respiratory tract and urinary tract infections. Products from the General Medicine division of Bayer Zydus Pharma include:

It is indicated for the treatment of productive cough
It is is indicated for the relief of symptoms associated with seasonal allergic rhinitis, perennial allergic rhinitis, acute and chronic disorders of respiratory tract associated with abnormal bronchial secretions, exacerbation of chronic bronchitis, asthmatic bronchitis and bronchial asthma.
It is indicated for relief of symptoms associated with allergic rhinitis, such as sneezing, nasal discharge (rhinnorhea) and itching, as well as ocular itching and burning. It is also indicated for relief of symptoms and signs of chronic urticaria.
It is indicated for relief of symptoms associated with allergic rhinitis, such as sneezing, nasal discharge (rhinnorhea) and itching, as well as ocular itching and burning. It is also indicated for relief of symptoms and signs of chronic urticaria.
It is used in treatment of infections caused by susceptible strains of the designated microorganisms in the condition and patient populations suffering from infection like urinary tract infection, lower respiratory tract infection, skin and soft tissue infections and others.
It is used in treatment of infections caused by susceptible strains of the designated microorganisms in the condition and patient populations suffering from infection like diarrhoea, dysentry, genitourinary tract infections, mixed bacterial infections.
The formulation can be used as a suppliment in cases of old age, general debility, convalescence from illness after major surgery, chronic diseases and following prolonged antibiotic therapy.
It is indicated for infection of the genital region (vaginitis) and infectious vaginal discharge caused by fungi ( Candida) and superinfections caused by Clotrimazole-sensitive bacteria.
It is indicated for the topical treatment of Dermatomycoses caused by dermatophytes, yeasts, moulds etc( eg tinea pedis, tinea manuum, Tinea corporis, tinea inguinalis, pityriasis versicolor) & erythrasma.
It is indicated for the topical treatment of Dermatomycoses caused by dermatophytes, yeasts, moulds etc( eg tinea pedis, tinea manuum, Tinea corporis, tinea inguinalis, pityriasis versicolor) & erythrasma.
It is indicated for the topical treatment of dermatomycoses including tinia pedis, tinia manum, tinia inguianalis, tinia cruris and tinia corporis, other dermatomycosis caused by sensitive yeast, moulds with coexisting symptoms of inflammation requiring rapid relief.
It is indicated for the topical treatment of Dermatomycoses caused by dermatophytes, yeasts, moulds etc( eg tinea pedis, tinea manuum, Tinea corporis, tinea inguinalis, pityriasis versicolor) & erythrasma.
It is indicated for infection of the genital region (vaginitis) and infectious vaginal discharge caused by fungi ( Candida) and superinfections caused by Clotrimazole-sensitive bacteria.
Its usage is adjunct to diet and exercise to lower the blood glucose in patients with non-insulin-dependent (Type II) diabetes mellitus (NIDDM) whose hyperglycemia cannot be controlled by diet and exercise alone.
It is indicated in the treatment of Type II diabetes mellitus (NIDDM) as a second line therapy when diet, exercise or treatment with either glimepiride or metformin does not result in adequate glycaemic control.
It is indicated for treatment of type II diabetes mellitus inadequately controlled by diet and/ or oral hypoglycaemic agents, As an adjuvant to diet and insulin in type - I Diabetes Mellitus and to lower the postprandial blood glucose in individuals with impaired glucose tolerance.
It is used in the treatment of patients with type II Diabetes mellitus, when diet, exercise and single agent do not result in adequate glycaemic control .
It is indicated for the prophylaxis and chronic treatment of asthma in adults. It is also indicated for the relief of symptoms of allergic rhinitis (seasonal allergic rhinitis and perennial allergic rhinitis in adults).
The treatment with this product includes symptomatic management of seasonal and perenial allergic rhinitis and uncomplicated skin manifestations of chronic idiopathic urticaria.
The treatment with this product includes symptomatic management of seasonal and perenial allergic rhinitis and uncomplicated skin manifestations of chronic idiopathic urticaria.
The treatment with this product includes symptomatic management of seasonal and perenial allergic rhinitis and uncomplicated skin manifestations of chronic idiopathic urticaria.
It is indicated for the treatment of allergic rhinitis in adults only.
Its usage is adjunct to diet and exercise to improve glycemic control in type 2 diabetes mellitus.
It is used in the treatment of skin mycosis caused by dermatophytes, yeast, moulds and other fungi.
It is used for the reduction of atherosclerotic events (myocardial infarction, stroke, and vascular death) in patients with atherosclerosis.
Anti histaminic agent
Anti histaminic agent
Prophylaxis & treatment of acute attacks of malaria due to P. Vivax, P. Malariae, P. Ovale and susceptible strains of P. Falciparum; Extraintestinal amoebiasis when nitroimidazole products are ineffective or cannot be used ; Treatment of rheumatoid arthritis; For the treatment of Systemic lupus erythematosus; Prophylaxis of malaria for pregnant women and non-immune individuals at risk.
It is used - as an adjunctive therapy to diet for the treatment of adult patients with hypertriglyceridemia. - as an adjunctive therapy to diet to slow the progression of atherosclerosis in adult patients as part of a treatment strategy to lower Total-C and LDL-C to target levels. - for risk reduction of myocardial infarction, stroke and arterial revascularization procedure in patients without clinically evident Coronary Heart Disease but with multiple risk factors.
"It is indicated for prevention of venous thromboembolism (VTE)in adult patients undergoing elective hip or knee replacement sugery (10mg). It is also indicated for prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. (SPAF) (15mg, 20mg) ; treatment of DVT and for the prevention of recurrent DVT and Pulmonary Embolism (PE) (15mg, 20mg)"
It is Indicated for treatment of mild to moderate hypertension
It is indicated for the treatment of essential hypertension in adults
It is indicated for treatment of mild to moderate hypertension in adults( not indicated for initial therapy)